de la Fuente, J., Kocan, K.M. and Blouin, E.F., 2007. Tick vaccines and the transmission of tick-borne pathogens. Veterinary Research Communications, 31(Suppl. 1), 85–90
Abstract
Ticks transmit pathogens that cause diseases which greatly impact both human and animal health. Vaccines developed against Boophilus spp. using Bm86 and Bm95 tick gut antigens demonstrated the feasibility of using vaccines for control of tick infestations. These vaccines also reduced transmission of tick-borne pathogens by decreasing exposure of susceptible hosts to ticks. The recently discovered tick antigens, 64P putative cement protein and subolesin involved in the regulation of tick feeding and reproduction, were also shown to reduce tick infestations. These antigens, together with the TROSPA receptor for Burrelia burgdorferi OspA were effective against tick-borne pathogens by reducing the infection levels in ticks and/or the transmission of the pathogen. Development of a vaccine targeted at both the tick vector and pathogen would contribute greatly to the control of tick infestations and the transmission of tick-borne diseases. These results have demonstrated that tick vaccines can be developed for control tick infestations and show promise for the prevention of the transmission of tick-borne pathogens.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
de la Fuente J. and Kocan K.M., 2003. Advances in the identification and characterization of protective antigens for development of recombinant vaccines against tick infestations. Expert Review of Vaccines, 2, 583–593
de la Fuente J. and Kocan K.M., 2006. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunology, 28, 275–283
de la Fuente J., Rodriguez M., Redondo M., Montero C., García-García J.C., Méndez L., Serrano E., Valdés M., Enriquez A., Canales M., Ramos E., Boué O., Machado H., Lleonart R., de Armas C.A., Rey S., Rodríguez J.L., Artiles M., García L., 1998. Field studies and cost-effectiveness analysis of vaccination with Gavac™ against the cattle tick Boophilus microplus. Vaccine, 16, 366–373
de la Fuente J., Almazán C., Blouin E.F., Naranjo V., Kocan K.M., 2006a. Reduction of tick infections with Anaplasma marginale and A. phagocytophilum by targeting the tick protective antigen subolesin. Parasitology Research, in press
de la Fuente J., Canales M., Kocan K.M., 2006b. The importance of protein glycosylation in development of novel tick vaccine strategies. Parasite Immunology, in press
Dinglasan R.R. and Jacobs-Lorena M., 2005. Insight into a conserved lifestyle: protein-carbohydrate adhesion strategies of vector-borne pathogens. Infection and Immunity, 73, 7797–7807
Estrada-Peña A. and Jongejan F., 1999. Ticks feeding on humans: a review of records on human-biting Ixodoidea with special reference to pathogen transmission. Experimental and Applied Acarology, 23, 685–715
Graf J.F., Gogolewski R., Leach-Bing N., Sabatini G.A., Molento M.B., Bordin E.L., Arantes G.J., 2004. Tick control: an industry point of view. Parasitology, 129, S427–S442
Gomes-Solecki M.J.C., Brisson D.R., Dattwyler R.J., 2006. Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait. Vaccine, 24, 4440–4449
Grimes J., 2006. Koch’s postulates-Then and now. Microbe, 1, 223–228
Koch R., 1884. Die Aetiologie der Tuberkulose. Mittheilungen aus dem Kaiserlichen Gesundheitsamte, 2, 1–88
Labuda M., Trimnell A.R., Lickova M., Kazimirova M., Davies G.M., Lissina O., Hails R.S., Nuttall P.A., 2006. An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen. PLoS Pathogens, 2(4), e27
Nuttall P.A., Trimnell A.R., Kazimirova M., Labuda M., 2006. Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases. Parasite Immunology, 28, 155–163
Pal U., Li X., Wang T., Montgomery R.R., Ramamoorthi N., Desilva A.M., Bao F., Yang X., Pypaert M., Pradhan D., Kantor F.S., Telford S., Anderson J.F., Fikrig E., 2004. TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell, 119, 457–468
Parola P. and Raoult D., 2001. Tick-borne bacterial diseases emerging in Europe. Clinical Microbiology and Infection, 7, 80–83
Rodríguez Valle M., Méndez L., Valdez M., Redondo M., Espinosa C.M., Vargas M., Cruz R.L., Barrios H.P., Seoane G., Ramírez E.S., Boué O., Vigil J.L., Machado H., Nordelo C.B., Piñeiro M.J., 2004. Integrated control of Boophilus microplus ticks in Cuba based on vaccination with the anti-tick vaccine Gavac. Experimental and Applied Acarology, 34, 375–382
Sukumaran B., Narasimhan S., Anderson J.F., DePonte K., Marcantonio N., Krishnan M.N., Fish D., Telford S.R., Kantor F.S., Fikrig E., 2006. An Ixodes scapularis protein required for survival of Anaplasma phagocytophilum in tick salivary glands. Journal of Experimental Medicine, 203, 1507–1517
Tsao J.I., Wootton J.T., Bunikis J., Luna M.G., Fish D., Barbour A.G., 2004. An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proceedings of the National Academy of Sciences U S A, 101, 18159–18164
Willadsen P., 2004. Anti-tick vaccines. Parasitology, 129, S367–387
Willadsen P., 2006. Tick control: Thoughts on a research agenda. Veterinary Parasitology, 138, 161–168
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de la Fuente, J., Kocan, K.M. & Blouin, E.F. Tick Vaccines and the Transmission of Tick-Borne Pathogens. Vet Res Commun 31 (Suppl 1), 85–90 (2007). https://doi.org/10.1007/s11259-007-0069-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-007-0069-5